Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 6Neoplasms 2Multiple Myeloma 2Gastrointestinal Neoplasms 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Tooth, Impacted 1Stomach Neoplasms 1Sepsis 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Postoperative Nausea and Vomiting 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Menstruation Disturbances 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma 1Lymphedema 1Lung Neoplasms 1Insulin Resistance 1Ileus 1Hyperandrogenism 1Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

Gemcitabine 83Cisplatin 59pembrolizumab 28Paclitaxel 21Nivolumab 21Carboplatin 21Cystectomy 20Docetaxel 18durvalumab 17atezolizumab 17Magnetic Resonance Spectroscopy 16Specimen Handling 15Radiotherapy 14avelumab 13Mitomycin 13Sunitinib 12Doxorubicin 12Methotrexate 11Fluorouracil 11Vinblastine 10Filgrastim 7BCG Vaccine 7Sorafenib 6Ipilimumab 6Immunoglobulin G 6Disulfides 6Biopsy 6enfortumab vedotin 5cabozantinib 5Trastuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Urinary Bladder Neoplasms × Acupuncture Therapy × Clear all
NCT04496219 2024-01-02

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
45 enrolled 16 charts
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡